PriceTargets.com logo

BioSig Technologies - BSGM Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $2.50
  • Forecasted Upside: 171.74%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.92 As of 04/25/2025 05:00 PM ET
▲ +0.08 (9.52%)

This chart shows the closing price for BSGM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New BioSig Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BSGM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BSGM

Analyst Price Target is $2.50
▲ +171.74% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for BioSig Technologies in the last 3 months. The average price target is $2.50, with a high forecast of $2.50 and a low forecast of $2.50. The average price target represents a 171.74% upside from the last price of $0.92.

This chart shows the closing price for BSGM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in BioSig Technologies.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/30/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/28/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/29/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/28/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/21/2025Ascendiant Capital MarketsLower TargetBuy ➝ Buy$2.75 ➝ $2.50
12/5/2024Ascendiant Capital MarketsBoost TargetBuy ➝ Buy$2.50 ➝ $2.75
4/10/2023Taglich BrothersReiterated RatingSpeculative Buy
2/13/2023Ascendiant Capital MarketsInitiated CoverageBuy$50.00
11/17/2022Noble FinancialLower Target$20.00
9/15/2022Taglich BrothersReiterated RatingSpeculative Buy
(Data available from 4/28/2020 forward)

News Sentiment Rating

-0.45 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/29/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/29/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/28/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/27/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/29/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
4/28/2025

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
BioSig Technologies logo
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Read More

Today's Range

Now: $0.92
Low: $0.72
High: $0.95

50 Day Range

MA: $0.69
Low: $0.48
High: $1.10

52 Week Range

Now: $0.92
Low: $0.20
High: $2.57

Volume

963,311 shs

Average Volume

220,737 shs

Market Capitalization

$15.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.79

Frequently Asked Questions

What sell-side analysts currently cover shares of BioSig Technologies?

The following sell-side analysts have issued research reports on BioSig Technologies in the last year: Ascendiant Capital Markets.
View the latest analyst ratings for BSGM.

What is the current price target for BioSig Technologies?

0 Wall Street analysts have set twelve-month price targets for BioSig Technologies in the last year. Their average twelve-month price target is $2.50, suggesting a possible upside of 171.7%. Ascendiant Capital Markets has the highest price target set, predicting BSGM will reach $2.50 in the next twelve months. Ascendiant Capital Markets has the lowest price target set, forecasting a price of $2.50 for BioSig Technologies in the next year.
View the latest price targets for BSGM.

What is the current consensus analyst rating for BioSig Technologies?

BioSig Technologies currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BSGM will outperform the market and that investors should add to their positions of BioSig Technologies.
View the latest ratings for BSGM.

What other companies compete with BioSig Technologies?

Other companies that are similar to BioSig Technologies include Baird Medical Investment, Outset Medical, TELA Bio, Modular Medical and Femasys. Learn More about companies similar to BioSig Technologies.

How do I contact BioSig Technologies' investor relations team?

BioSig Technologies' physical mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The company's listed phone number is (230) 409-5444 and its investor relations email address is [email protected]. The official website for BioSig Technologies is www.biosig.com. Learn More about contacing BioSig Technologies investor relations.